Research - Copenhagen, Capital Region of Denmark, Denmark
BioPhenyx is the first company in the world that accurately and experimentally determines how genetic sequence variants/mutations ("what is coded?") impact cell phenotypes ("what happens?")BioPhenyx can do this on a small or grand scale, across all major organisms, all genes, and all small mutations – including mutations that cause disease – or are otherwise difficult to assess accurately.BioPhenyx uses this capability to provide service offerings to leading corporations in the Pharma/Biotech, In Vitro Diagnostics and Life Science industries, as well as for groundbreaking internal R&D activities.
Outlook
WordPress.org
Google Font API
Mobile Friendly